{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:15Z","timestamp":1787024535181,"version":"build-2736575974"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[1993,8]]},"DOI":"10.2165\/00019053-199304020-00007","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T06:27:35Z","timestamp":1196836055000},"page":"131-156","source":"Crossref","is-referenced-by-count":18,"title":["Clozapine"],"prefix":"10.1007","volume":"4","author":[{"given":"Andrew","family":"Fitton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Benfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":["PharmacoEconomics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T09:13:07Z","timestamp":1358673187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00019053-199304020-00007"}},"subtitle":["An Appraisal of its Pharmacoeconomic Benefits in the Treatment of Schizophrenia"],"short-title":[],"issued":{"date-parts":[[1993,8]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.2165\/00019053-199304020-00007","relation":{},"ISSN":["1170-7690"],"issn-type":[{"value":"1170-7690","type":"print"}],"subject":[],"published":{"date-parts":[[1993,8]]}}}